OakChart

Viemed Healthcare Inc

VMDHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

9.13+0.15 (1.67%)
2026-11-12 01:06 CET
Market cap
340.28 USD m
Revenue, TTM
310.37 USD m
Net income, TTM
15.62 USD m
Free cash flow, TTM
21.38 USD m
EPS diluted, TTM
0.39
P/E
23.30
Compare

Price

VMD against its 20, 50 and 200-day averages
2050200miss
8.0010.0012.00537K1.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VMDclose 9.1320-day 9.5750-day 9.27200-day 9.649.1352w high

27.6% under the 52-week high of 12.61 on 13 Jul 2026. 52-week low 6.18 on 19 Nov 2025. Last 15 sessions, 17.2% high to low

Volume 0.66× normal · the line is the 50-bar volume average

Profile

VMD
52-week range, 46% of the way up
6.1812.61

Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. The firm supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.

IndexRUT
Employees1382
IPOJan 04, 2018
Beta1.05
ATR, 14d0.36
Rel volume0.66
Short float4.63%
Insider own13.94%
Inst own68.93%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap345.96M
Enterprise Value347.46M
Income15.62M
Sales310.37M
Book/sh3.94
Cash/sh0.26
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees1382
IPOJan 04, 2018

Ratios

P/E23.30
Forward P/E17.67
PEG0.99
P/S1.11
P/B2.31
P/C35.74
P/FCF16.18
EV/EBITDA6.16
EV/Sales1.12
Quick Ratio1.16
Current Ratio1.25
Debt/Eq0.06
LT Debt/Eq0.05
Option/ShortYes / Yes

Earnings

EPS (ttm)0.39
EPS next Y0.52
EPS next Q0.15
EPS this Y9.01%
EPS next Y28.10%
EPS next 5Y17.81%
EPS past 3/5Y32.77% -14.01%
Sales past 3/5Y24.87% 15.53%
EPS Y/Y TTM17.67%
Sales Y/Y TTM21.81%
EPS Q/Q29.87%
Sales Q/Q12.18%
EarningsNov 05 BMO
EPS/Sales Surpr.-10.79% -0.10%

Ownership

Insider Own13.94%
Insider Trans-0.56%
Inst Own68.93%
Inst Trans4.80%
ROA7.62%
ROE11.01%
ROIC9.92%
Gross Margin56.91%
Oper. Margin8.36%
Profit Margin5.03%
SMA20-4.56%
SMA50-1.54%
SMA200-5.31%
Trades-

Technical

Shs Outstand38.05M
Shs Float32.61M
Short Float4.63%
Short Ratio5.19
Short Interest1.51M
52W High12.61 -27.60%
52W Low6.18 47.73%
Volatility5.96% 3.51%
ATR (14)0.36
RSI (14)44.41
Beta1.05
Rel Volume0.66
Avg Volume290.76K
Volume190,998

Performance

Perf Week-9.69%
Perf Month-4.99%
Perf Quarter-0.44%
Perf Half Y-3.79%
Perf YTD22.88%
Perf Year43.78%
Perf 3Y27.87%
Perf 5Y58.78%
Perf 10Y-
Recom2.00
Target Price12.00
Prev Close8.98
Price9.13
Change %1.67%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Aug 24, 2026InitiatedBBarrington ResearchOutperform$14+53.3%
Mar 05, 2021InitiatedRRBC Capital MktsOutperform$13+42.4%

Peers

Mkt cap
TickerCompanyMkt cap
AHCOAdaptHealth Corp1.06B
INGNInogen Inc149.51M
ELMDElectromed Inc206.84M
INFUInfuSystem Holdings Inc302.10M
RMDResmed Inc33.55B
PHGKoninklijke Philips NV ADR29.52B
OPCHOption Care Health Inc4.75B
AVAHAveanna Healthcare Holdings Inc2.86B
ADUSAddus HomeCare Corp2.34B
PNTGPennant Group Inc1.29B

Insider trading

9 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Frazier WilliamChief Medical OfficerJun 25 '26Option Exercise1.8110,00018,10083,214Jun 26 04:06 PM
Frazier WilliamChief Medical OfficerJun 25 '26Sale11.7210,000117,20073,214Jun 26 04:06 PM
Smokoff TimothyDirectorJun 24 '26Sale11.5020,000229,96775,518Jun 26 04:04 PM
Moore MichaelPresidentMar 20 '26Sale8.7765,000570,0501,585,812Mar 20 05:06 PM
Moore MichaelPresidentMar 19 '26Sale9.2140,232370,5371,650,812Mar 20 05:06 PM
Moore MichaelPresidentMar 18 '26Sale9.4231,570297,3891,691,044Mar 20 05:06 PM
MOORE FASTER LLCOfficerMar 20 '26Proposed Sale8.7765,000570,115Mar 20 04:15 PM
MOORE FASTER LLCOfficerMar 19 '26Proposed Sale9.2140,232370,420Mar 19 04:11 PM
MOORE FASTER LLCOfficerMar 18 '26Proposed Sale9.4231,570297,345Mar 18 04:16 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
FSMDFidelity Small-Mid Multifactor ETFAUM: 2.48B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
VFMFVanguard U.S. Multifactor ETFAUM: 1.16B
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFAUM: 1.06B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.1100.1230.11080.7080.783
2026Q22026-08-030.0700.1200.06778.1078.002
2026Q12026-05-050.0600.0900.06475.4174.402
2025Q42026-03-040.1400.1250.14876.1877.702
2025Q32025-11-050.0900.0900.08771.9172.001
2025Q22025-08-060.0800.0850.07763.1063.252
2025Q12025-05-070.0600.0600.06359.1060.602
2024Q42025-03-100.1000.1050.10460.7059.952
2024Q32024-11-060.1000.0750.09558.0057.152
2024Q22024-08-070.0400.0700.03654.9753.801
2024Q12024-05-060.040-0.04050.5950.00-
2023Q42024-03-060.0900.1050.08650.7450.452
2023Q32023-11-010.0700.0950.07249.4049.502
2023Q22023-08-090.0600.0550.05743.3141.552
2023Q12023-05-080.0400.0470.03839.5638.483
2022Q42023-03-020.0600.0500.06237.5137.752

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY0.220-0.21546.93-
2018FY0.2600.2600.24065.2765.05
2019FY0.2100.2600.21580.2688.03
2020FY0.7800.5830.778131.31131.53
2021FY0.2200.2280.224117.06114.83
2022FY0.1600.1900.156138.83139.28
2023FY0.2500.3130.254183.01182.7
2024FY0.2800.2800.276224.26223.8
2025FY0.3700.3970.370270.28272
2026FY-0.403--317.66
2027FY-0.517--349.16
2028FY-0.605--382

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0630083.3083.2083.50
2026Q4S2026-11-0530083.4983.2083.70
2026Q4S2026-08-2130083.4983.2083.70
2026Q4S2026-08-0420083.4583.2083.70
2026Q4S2026-05-2320083.1582.8083.50
2026Q4S2026-05-1120183.1582.8083.50
2026Q4S2026-05-0620183.1082.8083.40
2026Q4S2026-03-0920183.1582.9083.40
2026Q4S2026-03-0510088.7088.7088.70
2026Q4S2026-01-0510088.7088.7088.70
2026Q4R2026-11-062100.160.140.17
2026Q4R2026-11-052000.150.140.16
2026Q4R2026-10-182000.150.140.16
2026Q4R2026-08-212100.150.140.16

Estimate history

EPS, annual0.2150.240.2150.7780.2240.1560.2540.2760.3660.3919
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0950.1040.0630.0770.0870.1480.0640.0670.113
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual46.92864.46480.256131.309117.062138.832183.008224.257270.28310.37
Period201720182019202020212022202320242025TTM
Sales, quarterly58.00460.69559.12963.05671.91476.18175.41478.09780.673
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual37.9137.50137.95339.18539.6438.0538.50639.13338.01938.053
Period201720182019202020212022202320242025MRQ
Shares, quarterly38.93239.13339.52439.60538.01838.01938.53438.08838.053
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue310.37270.28224.26183.01138.83117.06131.3180.2664.46
Cost of Goods Sold Incl. D&A133.75116.3192.5471.6255.1644.5052.0124.9217.28
Gross Profit176.62153.97131.72111.3983.6772.5679.3055.3447.19
Selling, General and Administrative Excl. Other150.88132.39115.2095.9876.0662.1558.7946.1237.01
Research and Development2.183.023.072.782.702.111.080.850.00
Other Operating Expense-0.22-0.250.17-0.10-0.99-1.62-0.450.110.07
Operating Income25.9621.8316.3515.518.6012.0320.959.1110.11
Interest Expense1.091.180.780.420.200.320.510.310.18
Unusual Expense0.211.120.350.05-0.94-1.24-3.59-0.360.20
Net Income Before Taxes22.8321.7716.1714.398.9912.5026.368.809.67
Income Taxes6.676.394.764.152.773.38-5.170.270.16
Consolidated Net Income16.1715.3811.4110.246.229.1331.538.539.51
Net Income From Continuing Operations15.6214.9311.2710.246.229.1331.538.539.51
Net Income15.6214.9311.2710.246.229.1331.538.539.51
EPS (Recurring)0.380.390.280.250.140.200.720.210.24
EPS (Basic, Before Extraordinaries)0.410.380.290.270.160.230.810.230.25
EPS (Diluted)0.390.370.280.250.160.220.780.210.24
EBITDA56.3950.4540.3537.4024.2323.3430.5415.5113.89
Non-Operating Income (Expense)-1.822.240.95-0.65-0.35-0.452.33-0.36-0.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.317.214.974.624.113.763.562.841.97
Price To Earnings Ratio22.9122.9131.2234.2638.6723.2610.0226.5514.80
Price To Sales Ratio1.211.121.461.732.171.812.393.072.34
Gross Margin56.9156.9758.7460.8760.2761.9860.3968.9573.20
Operating Margin8.368.087.298.486.1910.2715.9611.3515.68
Net Margin5.035.535.025.604.487.8024.0110.6214.75
Shares Outstanding38.0538.0239.1338.5138.0539.6439.1937.9537.50
Market Capitalization340.28340.28312.27302.14287.43206.87303.77235.31144.07

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue80.6778.1075.4176.1871.9163.0659.1360.70
Cost of Goods Sold Incl. D&A34.8733.4432.9832.4730.9726.6826.2024.90
Gross Profit45.8044.6642.4443.7240.9536.3832.9335.80
Selling, General and Administrative Excl. Other38.4839.6737.7534.9834.0331.9431.4530.52
Research and Development0.500.500.580.600.780.850.800.80
Other Operating Expense-0.06-0.07-0.04-0.06-0.04-0.07-0.07-0.09
Operating Income7.375.064.738.806.964.511.565.36
Interest Expense0.180.250.300.360.510.130.180.15
Unusual Expense0.000.000.070.140.850.050.090.01
Net Income Before Taxes6.794.053.998.015.134.963.666.30
Income Taxes2.051.151.282.191.531.710.951.88
Consolidated Net Income4.742.902.715.823.603.252.714.42
Net Income From Continuing Operations4.642.762.585.643.513.162.624.32
Net Income4.642.762.585.643.513.162.624.32
EPS (Recurring)0.110.070.070.150.100.080.060.10
EPS (Basic, Before Extraordinaries)0.120.070.070.150.090.080.070.11
EPS (Diluted)0.110.070.060.150.090.080.060.10
EBITDA15.0912.5812.3516.3714.5011.408.1711.72
Non-Operating Income (Expense)-0.41-0.76-0.36-0.29-0.480.642.371.10
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.961.611.941.821.721.851.831.20
Price To Earnings Ratio22.9130.3424.5622.4720.0423.1626.5031.22
Price To Sales Ratio1.211.551.301.051.081.181.301.48
Gross Margin56.7757.1956.2757.3856.9457.6955.6958.98
Operating Margin9.146.486.2711.559.697.162.638.83
Net Margin5.753.543.427.404.895.014.447.11
Shares Outstanding38.0538.0938.5338.0238.0239.6139.5239.13
Market Capitalization340.28437.04355.53282.47263.36273.11287.72312.27

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments13.5017.5412.8416.9128.4130.9813.3610.415.10
Short Term Receivables25.8124.9118.4515.4014.7212.3711.538.849.78
Inventories5.054.324.633.572.462.311.362.891.63
Other Current Assets4.136.112.453.851.731.511.560.950.49
Total Current Assets48.4952.8838.3739.7447.3147.1727.8123.0917.00
Net Property, Plant & Equipment82.3679.1676.8568.4462.8555.0654.7730.5620.69
Total Investments and Advances2.792.793.904.162.160.730.000.000.00
Intangible Assets60.2233.8430.33----0.000.00
Deferred Tax Assets21.088.404.563.124.798.73---
Other Assets0.000.000.891.590.860.860.010.000.00
Total Assets214.94177.07154.90117.04117.96112.5682.6053.6537.69
Short Term Debt Incl. Current Port. of LT Debt2.291.272.010.491.944.588.843.034.38
Accounts Payable7.335.324.182.653.242.104.705.883.39
Income Tax Payable0.003.882.15-0.000.340.090.150.14
Other Current Liabilities31.4326.8523.7915.7212.6316.0012.2810.505.24
Total Current Liabilities41.0637.3332.1218.8617.8123.0225.9119.5713.15
Long Term Debt13.655.608.320.204.576.5610.670.390.80
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities15.79--------
Other Liabilities0.920.850.560.890.761.292.321.120.00
Total Liabilities71.4243.7741.0019.9523.1430.8738.9021.0813.95
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity141.54131.39113.8997.0994.8281.6943.7032.5723.74
Total Shareholders Equity141.54131.39113.8997.0994.8281.6943.7032.5723.74
Accumulated Minority Interest1.981.910.000.000.000.000.000.000.00
Total Equity143.52133.30113.8997.0994.8281.6943.7032.5723.74
Total Liabilities & Stockholders Equity214.94177.07154.90117.04117.96112.5682.6053.6537.69
Book Value Per Share3.723.362.962.552.392.081.150.870.63
Tangible Book Value Per Share2.142.492.172.552.392.081.150.870.63
Full-Time Employees1,3821,179996743627511418--
Price to Book Ratio2.282.502.783.072.183.725.384.074.23
Return on Assets7.626.797.535.307.9232.3112.5320.8226.22
Return on Equity10.949.199.716.4810.3450.2921.6633.7744.65
Return on Invested Capital9.628.228.386.409.1835.7315.6828.8433.31
Quick Ratio1.061.301.051.922.521.951.021.031.17
Current Ratio1.181.421.192.112.662.051.071.181.29

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income16.1715.3811.4110.246.229.1331.538.539.51
Depreciation30.4328.6125.3721.8615.6311.319.586.403.78
Other Funds (Non Cash)11.387.125.806.7714.2911.7312.9313.699.16
Funds from Operations58.3654.2238.7337.4437.8836.0545.3128.6222.45
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-4.46-2.300.357.78-10.13-13.56-10.20-9.53-0.08
Income Taxes Payable3.84-4.111.732.181.87-2.230.25-0.070.01
Cash from Operating Activities53.9051.9239.0945.2127.7522.4935.1119.0922.37
Capital Expenditures-32.52-39.98-37.77-26.09-22.90-19.74-13.04-13.38-6.11
Net Assets From Acquisitions0.00-26.33-3.00-28.590.000.000.000.000.00
Sale of Fixed Assets and Businesses4.6816.1510.322.591.060.605.260.570.81
Purchase or Sale of Investments-0.550.00-1.00-0.02-2.14-0.60-0.630.000.00
Purchase of Investments-0.550.00-1.00-0.02-2.14-0.60-0.630.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.750.000.000.000.000.000.00
Cash from Investing Activities-28.40-50.17-30.70-52.11-23.98-19.75-8.41-12.81-5.30
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-6.67-11.791.021.30-9.290.111.88-1.13-1.59
Repurchase of Common Pref Stock-7.74-13.220.000.00-9.570.000.00-1.52-1.59
Sale of Common Pref Stock1.071.441.021.300.280.111.880.400.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-15.928.15-3.262.27-5.80-1.83-1.75-2.21-10.16
Change in Long Term Debt-15.928.15-3.262.27-5.80-1.83-1.75-2.21-10.16
Issuance of Long Term Debt-0.1221.892.8113.000.000.000.009.840.00
Reduction of Long Term Debt-15.80-13.73-6.07-10.73-5.80-1.83-1.75-12.04-10.16
Net Financing Active Other Cash Flow-4.37-2.11-1.10-0.59-0.14-1.430.000.000.00
Other Financing Activities Uses-4.37-2.11-1.10-0.59-0.14-1.430.000.000.00
Cash from Financing Activities-26.95-5.79-3.692.83-15.27-5.32-9.07-3.33-11.75
Net Change in Cash-1.45-4.044.70-4.08-11.49-2.5717.632.945.32
Free Cash Flow21.3811.931.3219.124.852.7522.075.7016.25
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow17.5425.42248.3016.5862.0577.1914.2543.229.28
Deferred Taxes & Investment Tax Credit-3.11-3.84-1.441.753.88-8.730.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments9.6810.689.7613.5011.1220.02
Short Term Receivables34.8932.2331.1825.8129.3326.55
Inventories4.555.275.185.055.274.32
Other Current Assets10.185.793.694.134.264.40
Total Current Assets59.2953.9749.8148.4949.9855.29
Net Property, Plant & Equipment79.8481.6979.3182.3684.1082.39
Total Investments and Advances3.183.182.792.792.792.79
Intangible Assets60.0360.1060.1660.2259.8133.77
Deferred Tax Assets5.295.295.2921.085.6710.36
Other Assets0.000.000.000.000.000.00
Total Assets207.63204.22197.36214.94202.36184.60
Short Term Debt Incl. Current Port. of LT Debt1.942.132.072.292.701.73
Accounts Payable10.6310.998.577.338.678.25
Income Tax Payable1.931.831.040.000.001.45
Other Current Liabilities32.8332.9429.0231.4332.8225.84
Total Current Liabilities47.3247.8940.7141.0644.1937.27
Long Term Debt7.349.4710.3713.6522.005.16
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---15.79--
Other Liabilities0.980.900.490.920.680.55
Total Liabilities55.6558.2651.5671.4266.8642.98
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity150.09144.03143.86141.54133.61139.73
Total Shareholders Equity150.09144.03143.86141.54133.61139.73
Accumulated Minority Interest1.901.941.931.981.891.89
Total Equity151.99145.96145.80143.52135.50141.62
Total Liabilities & Stockholders Equity207.63204.22197.36214.94202.36184.60
Book Value Per Share3.943.783.733.723.513.53
Tangible Book Value Per Share2.372.202.172.141.942.68
Full-Time Employees---1,382--
Price to Book Ratio2.283.052.472.111.922.03
Return on Assets7.627.467.937.627.328.02
Return on Equity11.0110.2210.6910.9410.5310.79
Return on Invested Capital2.951.801.673.632.262.18
Quick Ratio1.161.021.101.061.011.37
Current Ratio1.251.131.221.181.131.48

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income4.742.902.715.823.603.25
Depreciation7.727.527.627.577.546.89
Other Funds (Non Cash)2.952.862.872.702.711.73
Funds from Operations15.4113.2813.2116.4618.549.91
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.922.62-5.141.98-0.172.34
Income Taxes Payable0.100.791.261.69-3.36-0.43
Cash from Operating Activities11.4915.908.0718.4418.3712.25
Capital Expenditures-8.62-8.46-6.71-8.74-7.64-8.13
Net Assets From Acquisitions0.000.000.000.00-26.330.00
Sale of Fixed Assets and Businesses1.151.171.231.121.676.40
Purchase or Sale of Investments0.00-0.550.000.000.000.00
Purchase of Investments0.00-0.550.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-7.46-7.84-5.49-7.61-32.30-1.73
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.96-4.79-0.910.00-11.49-0.31
Repurchase of Common Pref Stock-0.98-5.32-1.440.00-11.56-1.66
Sale of Common Pref Stock0.010.530.530.000.071.36
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-2.14-2.18-3.24-8.3616.74-0.11
Change in Long Term Debt-2.14-2.18-3.24-8.3616.74-0.11
Issuance of Long Term Debt0.000.000.00-0.1222.000.00
Reduction of Long Term Debt-2.14-2.18-3.24-8.25-5.26-0.11
Net Financing Active Other Cash Flow-1.93-0.17-2.17-0.09-0.19-0.24
Other Financing Activities Uses-1.93-0.17-2.17-0.09-0.19-0.24
Cash from Financing Activities-5.03-7.15-6.33-8.455.04-0.67
Net Change in Cash-1.000.92-3.742.38-8.899.86
Free Cash Flow2.877.441.369.7010.734.12
Price to Free Cash Flow17.5416.0414.3923.6851.06-

Revenue breakdown

Equipment Sales2024: 30.90M 2025: 50.25M
Other Durable Medical Equipment Rentals2024: 48.65M 2025: 58.39M
Service2024: 20.13M 2025: 24.89M
Ventilator Rental2024: 124.58M 2025: 136.75M
United States2024: 224.26M 2025: 270.28M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.63%1.5M32.6M329.87K
2026-10-154.68%1.5M32.8M342.77K
2026-09-304.79%1.6M32.8M356.12K
2026-09-154.04%1.3M32.8M383.76K
2026-08-313.68%1.2M32.8M371.50K
2026-08-142.39%0.8M32.9M337.56K
2026-07-312.04%0.7M32.9M293.01K
2026-07-152.26%0.7M33.1M284.08K
2026-06-301.57%0.5M33.1M279.47K
2026-06-151.40%0.5M33.1M269.35K
2026-05-291.52%0.5M33.1M306.59K
2026-05-151.23%0.4M33.1M298.42K
2026-04-301.35%0.4M33.1M283.91K
2026-04-151.05%0.4M33.3M272.23K
2026-03-311.18%0.4M33.0M245.34K
2026-03-131.36%0.5M33.0M203.47K
2026-02-271.05%0.3M33.0M156.97K
2026-02-131.09%0.4M32.5M156.16K
2026-01-301.14%0.4M32.5M146.46K
2026-01-151.09%0.4M32.8M145.37K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.505.707.400.0010.4070.000.000.952-0.0640.001
call5.003.304.904.705.4582.000.000.895-0.0610.003
call7.500.802.401.782.81423.000.000.787-0.0470.004
call10.000.000.100.300.69163.000.000.189-0.0140.004
call12.500.000.200.201.4882570.000.108-0.0220.003
call15.000.000.750.002.0690.000.000.084-0.0260.002
call17.500.000.750.002.5240.000.000.072-0.0280.002
call20.000.000.750.002.8990.000.000.065-0.0300.002
call22.500.000.750.003.2170.000.000.061-0.0310.002
put2.500.000.750.007.9700.000.00-0.048-0.0640.001
put5.000.000.750.004.1570.000.00-0.105-0.0600.003
put7.500.000.400.051.9833.000.00-0.213-0.0460.004
put10.000.251.600.001.8920.000.00-0.784-0.0150.004
put12.502.704.200.003.2030.000.00-0.892-0.0210.003
put15.005.106.800.004.1740.000.00-0.916-0.0240.002
put17.507.609.300.004.7750.000.00-0.928-0.0260.002
put20.0010.1011.800.005.2640.000.00-0.935-0.0280.002
put22.5012.3014.700.006.4680.000.00-0.939-0.0290.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-09-24SCHEDULE 13D/ASEC
2026-08-208-KCurrent report2026-08-20SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-05S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-07-24SCHEDULE 13G/ASEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-25SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-06-028-KCurrent report2026-06-02SEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-04-22DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-22SEC
2026-04-22ARSAnnual report to security holders. 2025-12-31SEC
2026-03-20144Filing for proposed sale of securities under Rule 144.SEC
2026-03-204Statement of changes in beneficial ownership of securities2026-03-18SEC
2026-03-19144Filing for proposed sale of securities under Rule 144.SEC
2026-03-18144Filing for proposed sale of securities under Rule 144.SEC
2026-03-168-KCurrent report2026-03-16SEC
2026-03-0410-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-048-KCurrent report2026-03-04SEC
2026-02-024Statement of changes in beneficial ownership of securities2026-01-29SEC
2026-02-024Statement of changes in beneficial ownership of securities2026-01-29SEC
2026-02-024Statement of changes in beneficial ownership of securities2026-01-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0600347.17K2
2026-050000
2026-040000
2026-03001.24M3
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.12.49%
Forager Capital Management, LLC5.59%
VANGUARD CAPITAL MANAGEMENT LLC3.45%
Nantahala Capital Management, LLC3.30%
GOLDMAN SACHS GROUP INC3.19%
GEODE CAPITAL MANAGEMENT, LLC3.08%
AMERIPRISE FINANCIAL INC2.62%
RAFFLES ASSOCIATES LP2.11%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.05%
STATE STREET CORP1.99%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.38%
iShares Russell 2000 ETF2.27%
Columbia Small Cap Value Discovery Fund1.48%
BlackRock Advantage Small Cap Core Fund1.26%
First Eagle Small Cap Opportunity Fund1.22%
VANGUARD EXTENDED MARKET INDEX FUND0.97%
Fidelity Small Cap Index Fund0.97%
iShares Russell 2000 Growth ETF0.83%
VANGUARD RUSSELL 2000 INDEX FUND0.51%
Fidelity Extended Market Index Fund0.44%

OakChart. VMD. Cached 15 minutes.